Description
+ Include: videos + file sub vtt, size: GB
+ Target Audience: Cardiologists, Clinical Cardiac Electrophysiologists, Interventional Cardiologists, Heart Failure Specialists, Preventive Cardiologists
+ Sample video: contact me for sample video
+ Information:
The management of patients with cardiac disease continues to evolve. The goal of this program is to provide the most current evidence-based diagnostic and treatment strategies for your patients. Related areas to cardiology will be covered such as management of hypertension, pulmonary embolus of cardiac patients and management of heart failure. The program structure will focus on case-based presentations including lectures, breakfast cases, panel discussions, and use of our audience response system to provide opportunities for all participants to interact with the conference faculty.
Learning Objectives
-
Formulate evidence-based diagnostic, risk-stratification, and treatment algorithms for complex cardiac rhythm disorders, including atrial fibrillation, stroke prophylaxis, and ventricular arrhythmias.
-
Evaluate malfunctions and complications related to cardiac implantable electronic devices (pacemakers and defibrillators) and execute appropriate troubleshooting protocols.
-
Apply guideline-directed medical therapy (GDMT) and emerging pharmaceutical options (including GLP-1 receptor agonists and novel lipid-lowering therapies for Lp(a)) across heart failure phenotypes, notably HFpEF and cardiometabolic diseases.
-
Recognize, evaluate, and manage non-ischemic and infiltrative cardiomyopathies, including cardiac amyloidosis and fulminant myocarditis.
-
Integrate multimodality preventive imaging, cardiac genetics, and artificial intelligence tools to optimize cardiovascular risk assessment and heart failure care pathways.
-
Analyze indications, procedural strategies, and patient outcomes for contemporary catheter-based structural and coronary interventions, including TAVR, transcatheter tricuspid interventions, patent foramen ovale (PFO) closure, in-stent restenosis management, and renal denervation.
Target Audience
This three day program in clinical cardiology is designed for the cardiologist, primary care physician, internist, practicing cardiovascular specialist, cardiovascular nurse and physician assistant.
Best for Cardiologists, Clinical Cardiac Electrophysiologists, Interventional Cardiologists, Heart Failure Specialists, Preventive Cardiologists, Cardiovascular Radiologists, Endocrinologists, Hepatologists, Sleep Medicine Specialists, Neurologists, and Primary Care Physicians.
Topics
-
The First Pillar of AF Management – Risk Factor Modification with Focus on Obesity
-
Ventricular Arrhythmia Identification & Management
-
Optimizing Stroke Prophylaxis in Atrial Fibrillation Management
-
Cardiac Implantable Devices Gone Wrong – Diagnosis and Management of Malfunctioning Pacemakers and Defibrillators
-
Atrial Fibrillation in 2025 – Pearls for the non-EP
-
Update on Novel Therapies for Treating Elevated Lp(a)
-
HFpEF Is a Metabolic Disease – Evidence and Implications
-
Approach to Liver Disease in the Patient with Cardiometabolic Risk
-
Changing the Paradigm – The Top Recent Trials in Preventive Cardiology and Cardiometabolic Health
-
Update in Preventive Imaging
-
Best Cases of the Year – Dyspnea & Fulminant Myocarditis Cases
-
The Future Is Here – Artificial Intelligence and Imaging in Heart Failure
-
Transforming Heart Failure into Heart Success – Heart Failure Transitions of Care
-
Cardiac Genetics and Genomics
-
Don’t Sleep on It – Heart Failure and Sleep Disordered Breathing
-
Reaching a New Peak – Results of SUMMIT and GLP-1 Agonists in HFpEF
-
Emerging Treatment Strategies and Clinical Trials for Cardiac Amyloidosis
-
Pharmacy Integration into Multidisciplinary Heart Failure Clinics – Optimizing GDMT Despite Real-World Barriers
-
No Longer Limited Options – New and Emerging Treatments for HFpEF
-
Coronary Artery Disease Chest Pain Case Studies Discussion
-
Patent Foramen Ovale Closure – Secondary Stroke Prevention and More
-
Treatment of In-Stent Restenosis
-
Renal Denervation for Treatment of Hypertension
-
TBA Topic
-
New Treatments for Tricuspid Valve Disease
-
Update in TAVR (and Other Valves)





Reviews
There are no reviews yet.